Yuva Biosciences, Inc. — Form D
Yuva Biosciences, Inc. of BIRMINGHAM, AL, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-24. The offering totals $3.0M, of which $1.1M was reported sold. Industry: Other.
Offering
- Filed: 2026-03-24
- Form: D
- Accession: 0001998258-26-000003
- Industry: Other
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.1M
- Remaining: $1.9M
- Investors: 11
- Date of first sale: 2026-03-16
- Revenue range: Decline to Disclose
- SEC file number: 021-577488
Issuer
- Name: Yuva Biosciences, Inc.
- CIK: 0001998258
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1500 1ST AVENUE N, BIRMINGHAM, AL, 35203
- Phone: 2052508000
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Daniel Browne | Director | Birmingham, AL |
| Fred Ehrsam | Director | Birmingham, AL |
| Greg Schmergel | Director | Birmingham, AL |
| Greg Schmergel | Executive Officer | Birmingham, AL |
Other filings by this issuer (1)
More